This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message:
Sent on Thursday, 2009 Sep 17Search kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.
PubMed Results |
- 1: Parasitol Res. 2009 Sep 16. [Epub ahead of print]
-
Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi.
Laboratório de Patologia de Moléstias Infecciosas (LIM-50), Depto. de Patologia, Universidade de São Paulo, São Paulo, SP, Brazil, felipepassero@usp.br.
Since the first description of Leishmania (Viannia) shawi, few studies were performed with this parasite. In the present work, the in vivo and ex vivo behavior of L. (Viannia) shawi infection was studied using murine model. Peritoneal macrophages from BALB/c and C57BL/6 mice were infected with promastigotes in the stationary phase of growth; after 24 h, the infection index and nitric oxide (NO) levels in the supernatant of the cultures were analyzed. BALB/c and C57BL/6 mice were infected into the hind footpad, and at each 2 weeks, mice were sacrificed, and the histological changes of the skin inoculation site, parasitism, and humoral immune responses were evaluated during 8 weeks. Ex vivo experiments showed that macrophages of BALB/c presented higher infection index and lesser NO levels than macrophages of C57BL/6. In vivo experiments showed that BALB/c presented higher lesion size than C57BL/6 mice; similarly, the histopathological changes and the parasitism in skin were more exacerbate in BALB/c mice. In draining lymph nodes, the main change was increase of germinative centers, and parasites were detected from 6 weeks pi onwards in both mice strain. IgG was detected in BALB/c mice from 4 weeks, while in C57BL/6, from 6 weeks pi onwards. Taken together, these results indicate that BALB/c showed a classical behavior of susceptibility when compared to C57BL/6 mice.
PMID: 19756748 [PubMed - as supplied by publisher]
-
Related articles
- Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
Am J Trop Med Hyg. 2002 Mar; 66(3):273-9.
[Am J Trop Med Hyg. 2002]
- Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice.
Microbes Infect. 2004 Sep; 6(11):977-84.
[Microbes Infect. 2004]
- Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
Vet Parasitol. 2004 May 26; 121(3-4):179-87.
[Vet Parasitol. 2004]
- Leishmania (Viannia) panamensis-induced cutaneous leishmaniasis in Balb/c mice: pathology.
Int J Exp Pathol. 1993 Oct; 74(5):481-91.
[Int J Exp Pathol. 1993]
- ReviewMolecular survival strategies of Echinococcus multilocularis in the murine host.
Parasitol Int. 2006; 55 Suppl:S45-9. Epub 2005 Dec 13.
[Parasitol Int. 2006]
- » See reviews... | » See all...
- Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
- 2: Appl Biochem Biotechnol. 2009 Sep 8. [Epub ahead of print]
-
Rational Approaches for Drug Designing Against Leishmaniasis.
Department of Biotechnology, Indian Institute of Technology Guwahati, Guwahati, 781039, Assam, India.
Leishmaniasis has been ignored for many years mainly because it plagues remote and poor areas. However, recently, it has drawn attention of several investigators, and active research is going on for antileishmanial drug discovery. The current available drugs have high failure rates and significant side effects. Recently, liposomal preparations of amphotericin B are available and have proved to be a better drug, but they are very expensive. Miltefosine is one of the few orally administered drugs that are effective against Leishmania. However, it has exhibited teratogenicity, hence, should not be administered to pregnant women. Thus, the search for novel and improved antileishmanial drugs continue. A rational approach to design and develop new antileishmanials can be to identify several metabolic and biochemical differences between host and parasite that can be exploited as drug target. Moreover, many natural products also have significant antileishmanial activity and are yet to be exploited. In the current review, we aim to bring together various drug targets of Leishmania, recent development in the field, future prospects, and hope in the area.
PMID: 19756413 [PubMed - as supplied by publisher]
-
Related articles
- Review[Development of antituberculous drugs: current status and future prospects]
Kekkaku. 2006 Dec; 81(12):753-74.
[Kekkaku. 2006]
- Development of new antileishmanial drugs--current knowledge and future prospects.
J Enzyme Inhib Med Chem. 2008 Oct; 23(5):708-18.
[J Enzyme Inhib Med Chem. 2008]
- ReviewAntiparasitic chemotherapy: tinkering with the purine salvage pathway.
Adv Exp Med Biol. 2008; 625:116-32.
[Adv Exp Med Biol. 2008]
- ReviewLeishmaniasis: current treatment and prospects for new drugs and vaccines.
Curr Med Chem. 2009; 16(5):599-614.
[Curr Med Chem. 2009]
- ReviewCurrent scenario of drug development for leishmaniasis.
Indian J Med Res. 2006 Mar; 123(3):399-410.
[Indian J Med Res. 2006]
- » See reviews... | » See all...
- Review[Development of antituberculous drugs: current status and future prospects]
- 3: J Infect Dev Ctries. 2009 Mar 1;3(2):123-9.
-
Cutaneous leishmaniasis in Iraq.
Department of Medicine, Tikrit University College of Medicine, Tikrit, Iraq. galsamarrai@yahoo.com
OBJECTIVE: To determine the incidence ofcutaneous leishmaniasis (CL) in Alhaweja District and to clarify the secondary bacterial infection inCL. METHODOLOGY: A prospective survey was performed in the outpatient clinic of Alhaweja General Hospital. All the patients who presented at the dermatology clinic during the period from 1 October 2004 to the end of April 2005 were included in the study. The provisional diagnosis was dependent on clinical examination; however, biopsies and confirmatory tests were performed for questionable cases. Venous blood was drawn from patients with cutaneous leishmaniasis for determination of IgM. Swabs from the ulcer were taken for culture to determine secondary bacterial infections. RESULTS: A total of 107 cutaneous leishmaniasis cases were diagnosed during the study period with males representing 57% of the cases. The study participants ranged from 1-60 years. The incidence rate was 45 cases per 10,000. Clinically, 58% of patients had multiple lesions, while 42% had a single lesion. It was found that 36.5% of patients had dry type while 63.5% had wet type lesions. Most lesions were found on upper limbs (57%), while the fewest were found in the ear 1%. The highest number of cases was recorded during February (32.1%), while the lowest rate of cases was recorded in April (3.37%). According to cultures and smears, 73% of the cases were positive to giemsa stain and 43% were positive in cultures. Secondary bacterial infection occurred in 42% of lesions and Staphylococcus epidermidis was the most common bacteria (55%) isolated from lesions, followed by Staphylococcus aureus (33%). The mean of total IgM levels was significantly decreased in patients with CL in comparison with the control group. CONCLUSIONS: CL is endemic in Alhaweja district. CL is an important health problem since secondary bacterial infection was reported in 42% of cases and this infection my influence the natural course of the disease causing more destruction for skin. Giemsa stain was the most sensitive parasitic diagnostic test.
PMID: 19755742 [PubMed - in process]
-
Related articles
- Distribution frequency of pathogenic bacteria isolated from cutaneus leishmaniasis lesions.
Korean J Parasitol. 2008 Sep; 46(3):191-3.
[Korean J Parasitol. 2008]
- Histological grading patterns in patients of cutaneous leishmaniasis.
J Coll Physicians Surg Pak. 2007 Nov; 17(11):650-3.
[J Coll Physicians Surg Pak. 2007]
- [Tuberculosis in Iceland. 1976]
Laeknabladid. 2005 Jan; 91(1):69-102.
[Laeknabladid. 2005]
- Review[Aortoiliac graft infection as a diagnostic and treatment problem]
Ann Acad Med Stetin. 1998; Suppl 41:1-72.
[Ann Acad Med Stetin. 1998]
- Review[Feline leishmaniasis: what's the epidemiological role of the cat?]
Parassitologia. 2004 Jun; 46(1-2):203-6.
[Parassitologia. 2004]
- » See reviews... | » See all...
- Distribution frequency of pathogenic bacteria isolated from cutaneus leishmaniasis lesions.
- 4: J Infect Dev Ctries. 2009 Sep 15;3(2):115-22.
-
PCR detection of Leishmania in skin biopsies.
Laboratoire des recherche et d'étude sur les Leishmanioses, Institut Pasteur du Maroc, Casablanca, Morocco. meryem.lemrani@pasteur.ma
INTRODUCTION: Cutaneous leishmaniasis (CL) is an endemic disease and one of the major health problems in Morocco. In 2006, the recorded total number of cases of CL was 3361, occurring predominantly in the rural population. A new and more sensitive diagnostic technique than current methods used is needed in this setting. The aim of this study was to assess the efficacy of polymerase chain reaction (PCR) to detect leishmanial parasites in skin biopsies of patients from different areas of endemicity in Morocco. METHODOLOGY: Biopsies from 26 patients with cutaneous ulcers suggestive of leishmaniasis were analysed by PCR using primers from the small subunit ribosomal gene. The ability of PCR to detect Leishmania was compared with smear-stained and in vitro culture. RESULTS: PCR exhibited superior sensitivity (84,6%) compared with direct microscopy smear (69,2%) and in vitro culture (69,2%). Our PCR assay also showed good specificity (100%). CONCLUSIONS: PCR should be considered a valuable, sensitive, and faster diagnostic tool in the diagnosis of cutaneous leishmaniasis, especially for those patients with negative parasitologic examination.
PMID: 19755741 [PubMed - in process]
-
Related articles
- Polymerase chain reaction for diagnosis of cutaneous leishmaniasis in histologically positive, suspicious and negative skin biopsies.
Dermatology. 2002; 205(1):18-24.
[Dermatology. 2002]
- Leishmania (V.) braziliensis: detection by PCR in biopsies from patients with cutaneous leishmaniasis.
Exp Parasitol. 2008 Jul; 119(3):319-24. Epub 2008 Mar 14.
[Exp Parasitol. 2008]
- Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization.
J Clin Microbiol. 1994 Sep; 32(9):2246-52.
[J Clin Microbiol. 1994]
- Molecular diagnosis of leishmaniosis in the Paraná state of southern Brazil.
Exp Dermatol. 2008 Dec; 17(12):1024-30. Epub 2008 Jul 7.
[Exp Dermatol. 2008]
- ReviewClinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
Clin Infect Dis. 2007 Jun 15; 44(12):1602-10. Epub 2007 May 7.
[Clin Infect Dis. 2007]
- » See reviews... | » See all...
- Polymerase chain reaction for diagnosis of cutaneous leishmaniasis in histologically positive, suspicious and negative skin biopsies.
- 5: Biomedica. 2009 Mar;29(1):73-86.
-
[Sand flies (Diptera: Psychodidae) of Guaviare Province, Colombia, with 4 new records for the country]
[Article in Spanish]Grupo de Entomología, Subdirección de Investigación, Instituto Nacional de Salud, Bogota, D.C., Colombia. ocabrera@ins.gov.co
INTRODUCTION: Although cases of leishmaniasis have been reported in the province of Guaviare, Colombia, no entomological studies were included to identify the Lutzomyia sand fly vector species in that area. OBJECTIVE: Lutzomyia species were identified from four townships of Guaviare. Probable vectors were named based on those species involved in transmission in other areas. MATERIALS AND METHODS: Sampling was undertaken with CDC light traps suspended at heights between 1.5 m and 9 m. Additional sand flies were collected with Shannon traps and by aspiration of adult flies from daytime resting sites. RESULTS: Sand flies belonging to 37 different species were collected. 35 of them were recorded for the first time in Guaviare Province. Four species were new records for Colombia: Lutzomyia begonae, L. campbelli, L. sericea and L. nematoducta. The most abundant species were L. hirsuta 24.3% (148/610), L. yuilli 15.2% (93/610), L. davisi 10.3% (63/610), followed by L. fartigi, L. carrerai, L. antunesi, L. flaviscutellata and L. olmeca bicolor. CONCLUSION: Seven of these species of have been associated previously with endemic or epidemic transmission of leishmaniasis.
PMID: 19753841 [PubMed - in process]
-
Related articles
- Lutzomyia sand flies (Diptera: Psychodidae) from middle and lower Putumayo Department, Colombia, with new records to the country.
Mem Inst Oswaldo Cruz. 2000 Sep-Oct; 95(5):633-9.
[Mem Inst Oswaldo Cruz. 2000]
- [Lutzomyia longiflocosa as suspected vector of cutaneous leishmaniasis in a focus of cutaneous leishmaniasis on the sub-andean region of Tolima department, Colombia, and the knowledge on sandflies by the inhabitants]
Biomedica. 2006 Oct; 26 Suppl 1:95-108.
[Biomedica. 2006]
- Phlebotomine sand flies (Diptera: Psychodidae) associated with the appearance of urban Leishmaniasis in the city of Sincelejo, Colombia.
Mem Inst Oswaldo Cruz. 2002 Jul; 97(5):645-7.
[Mem Inst Oswaldo Cruz. 2002]
- [Species of Lutzomyia (Psychodidae, Phlebotominae) in endemic cutaneous and visceral leishmaniasis foci of the department of Santander, in the eastern range of the Colombian Andes]
Biomedica. 2006 Oct; 26 Suppl 1:218-27.
[Biomedica. 2006]
- Species composition and relative abundance of sand flies of the genus Lutzomyia (Diptera: Psychodidae) at an endemic focus of visceral leishmaniasis in Colombia.
J Med Entomol. 1995 Jul; 32(4):527-37.
[J Med Entomol. 1995]
- » See reviews... | » See all...
- Lutzomyia sand flies (Diptera: Psychodidae) from middle and lower Putumayo Department, Colombia, with new records to the country.
- 6: Biomedica. 2009 Mar;29(1):9-11.
-
[Mucosal complication of cutaneous leishmaniasis]
[Article in Spanish]Unidad Clínica, Centro Internacional de Entrenamiento e Investigaciones Médicas-CIDEIM, Call, Colombia. dzea@cideim.org.co
A 74-year-old man from the rural area of Caicedonia, Valle del Cauca Province, was diagnosed with uncontrolled hypertension, stage IV chronic renal failure and severe anemia. Fifteen years earlier, while living in Guaviare Province, he was diagnosed with leishmaniasis-with lesions located on the right upper and lower eyelids, left auricle and limbs. At that time, he received an incomplete treatment with antimonials. The patient had experienced 8 years of progressive mucosal lesions located in the upper lip, nasal mucosa and right upper and lower eyelids (figure 1). A histopathological diagnosis of leishmaniasis was made and confirmed by polymerase chain reaction (figure 2). Treatment with antimonials (Glucantime) was contraindicated due to the patient's comorbidities. Inpatient supervised treatment with miltefosine (Impavido 50 mg capsules) was initiated according to the national guidelines of 1.8 mg/kg/day for 28 days. Clinical follow up and routine laboratory tests (creatinine, BUN, liver function tests and complete blood counts) were done during and after treatment; no complications were reported. Medical follow up was continued until the Internal medicine, ophthalmology, and plastic surgery consultations were provided for subsequent management of the pathology. Mucocutaneous leishmaniasis is a serious preventable complication of cutaneous leishmaniasis. This case illustrated a failure in opportune diagnosis and treatment of this disease as a consequence of an inadequate leishmaniasis control program. The case indicated the effectiveness of miltefosine as a therapeutic option in patients for whom antimonial treatment is contraindicated.
PMID: 19753833 [PubMed - in process]
-
Related articles
- Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment.
Bull Pan Am Health Organ. 1994 Jun; 28(2):142-55.
[Bull Pan Am Health Organ. 1994]
- First case of typical Old World cutaneous leishmaniasis treated with miltefosine.
Int J Dermatol. 2007 Apr; 46(4):385-7.
[Int J Dermatol. 2007]
- [Diffuse cutaneous leishmaniasis in a patient with AIDS]
Biomedica. 2006 Dec; 26(4):485-97.
[Biomedica. 2006]
- ReviewLeishmaniasis: recognition and management with a focus on the immunocompromised patient.
Am J Clin Dermatol. 2002; 3(2):91-105.
[Am J Clin Dermatol. 2002]
- ReviewInterventions for American cutaneous and mucocutaneous leishmaniasis.
Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004834. Epub 2009 Apr 15.
[Cochrane Database Syst Rev. 2009]
- » See reviews... | » See all...
- Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment.
-
Structural effects of a dimer interface mutation on catalytic activity of triosephosphate isomerase. The role of conserved residues and complementary mutations.
Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
The active site of triosephosphate isomerase (TIM, EC: 5.3.1.1), a dimeric enzyme, lies very close to the subunit interface. Attempts to engineer monomeric enzymes have yielded well-folded proteins with dramatically reduced activity. The role of dimer interface residues in the stability and activity of the Plasmodium falciparum enzyme, PfTIM, has been probed by analysis of mutational effects at residue 74. The PfTIM triple mutant W11F/W168F/Y74W (Y74W*) has been shown to dissociate at low protein concentrations, and exhibits considerably reduced stability in the presence of denaturants, urea and guanidinium chloride. The Y74W* mutant exhibits concentration-dependent activity, with an approximately 22-fold enhancement of k(cat) over a concentration range of 2.5-40 microM, suggesting that dimerization is obligatory for enzyme activity. The Y74W* mutant shows an approximately 20-fold reduction in activity compared to the control enzyme (PfTIM WT*, W11F/W168F). Careful inspection of the available crystal structures of the enzyme, together with 412 unique protein sequences, revealed the importance of conserved residues in the vicinity of the active site that serve to position the functional K12 residue. The network of key interactions spans the interacting subunits. The Y74W* mutation can perturb orientations of the active site residues, due to steric clashes with proximal aromatic residues in PfTIM. The available crystal structures of the enzyme from Giardia lamblia, which contains a Trp residue at the structurally equivalent position, establishes the need for complementary mutations and maintenance of weak interactions in order to accommodate the bulky side chain and preserve active site integrity.
PMID: 19583769 [PubMed - indexed for MEDLINE]
-
Related articles
- Subunit interface mutation disrupting an aromatic cluster in Plasmodium falciparum triosephosphate isomerase: effect on dimer stability.
Protein Eng. 2002 Jul; 15(7):575-84.
[Protein Eng. 2002]
- Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design.
Structure. 1997 Jun 15; 5(6):751-61.
[Structure. 1997]
- Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: characterization of catalytic loop open and closed conformations in the ligand-bound state.
Biochemistry. 2002 Nov 5; 41(44):13178-88.
[Biochemistry. 2002]
- Unusual fluorescence of W168 in Plasmodium falciparum triosephosphate isomerase, probed by single-tryptophan mutants.
Eur J Biochem. 2003 Feb; 270(4):745-56.
[Eur J Biochem. 2003]
- Structures of unliganded and inhibitor complexes of W168F, a Loop6 hinge mutant of Plasmodium falciparum triosephosphate isomerase: observation of an intermediate position of loop6.
J Mol Biol. 2004 Oct 22; 343(3):671-84.
[J Mol Biol. 2004]
- » See reviews... | » See all...
- Subunit interface mutation disrupting an aromatic cluster in Plasmodium falciparum triosephosphate isomerase: effect on dimer stability.
-
New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Departamento de Química Orgánica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
A series of novel benzoimidazo and N-aryl-5-oxo-imidazo[1,2-b]isoquinoline-10-carbothioamides was developed. All the compounds were evaluated for their in vitro action against the epimastigote form of Trypanosoma cruzi. Four of them showed higher activity than Nifurtimox. Their unspecific cytotoxicity was evaluated using HeLa and L6 cells, being non-toxic at concentrations at least 15 and 200 times higher than that of T. cruzi IC(50.) To gain insight into the mechanism of action, their DNA binding properties and reactivity with glutathione were studied, and QSAR study was performed.
PMID: 19168363 [PubMed - indexed for MEDLINE]
-
Related articles
- In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.
J Med Chem. 2007 Nov 29; 50(24):6004-15. Epub 2007 Oct 26.
[J Med Chem. 2007]
- 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.
J Med Chem. 2006 Jun 1; 49(11):3215-24.
[J Med Chem. 2006]
- Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
Bioorg Med Chem. 2008 Jan 15; 16(2):668-74. Epub 2007 Oct 18.
[Bioorg Med Chem. 2008]
- Review[The chemotherapy of Chagas disease]
Medicina (B Aires). 1999; 59 Suppl 2:147-65.
[Medicina (B Aires). 1999]
- ReviewAnti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
Mini Rev Med Chem. 2008 Nov; 8(13):1355-83.
[Mini Rev Med Chem. 2008]
- » See reviews... | » See all...
- In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.
No comments:
Post a Comment